| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 132, Issue 1 197-202, Copyright © 1984 by American Association of Immunologists
ARTICLES |
AL Cunningham and TC Merigan
Interferon-gamma (IFN-gamma) was spontaneously secreted by peripheral blood mononuclear cells cultured from patients soon after recurrent herpes labialis (RHL) or was induced from macrophage-T lymphocyte cultures in vitro with HSV antigen. Circulating Leu-3+/Leu-2- cells produced the spontaneous IFN almost exclusively. In the HSV antigen- stimulated culture system the same subset was the predominant producer of IFN-gamma. The IFN-gamma producing leu-3+ lymphocytes were plastic nonaderent but nylon wool adherent, and may be analagous to the murine Th 2 helper cell. In contrast to one lymphocyte subset being the major IFN-gamma producer in this viral disease, mitogen stimulation induced IFN-gamma from all (Leu-2+/2- and Leu-3+/3-) subsets, with panning as the separation technique. As mitogens circumvent the normal processing and presentation of antigen, the RHL system described above may provide a more accurate picture of the relative contributions of helper (Leu- 3+) and cytotoxic/suppressor (Leu-2+) T cells to IFN-gamma production in herpes viral disease.
This article has been cited by other articles:
|
|
 |
|
  M. E. Dobbs, J. E. Strasser, C.-F. Chu, C. Chalk, and G. N. Milligan Clearance of Herpes Simplex Virus Type 2 by CD8+ T Cells Requires Gamma Interferon and either Perforin- or Fas-Mediated Cytolytic Mechanisms J. Virol., December 1, 2005; 79(23): 14546 - 14554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Koelle and L. Corey Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research Clin. Microbiol. Rev., January 1, 2003; 16(1): 96 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mikloska and A. L. Cunningham Alpha and Gamma Interferons Inhibit Herpes Simplex Virus Type 1 Infection and Spread in Epidermal Cells after Axonal Transmission J. Virol., December 1, 2001; 75(23): 11821 - 11826. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Weinberg In Vitro Hydroxyurea Decreases Th1 Cell-Mediated Immunity Clin. Vaccine Immunol., July 1, 2001; 8(4): 702 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Mikloska, M. Ruckholdt, I. Ghadiminejad, H. Dunckley, M. Denis, and A. L. Cunningham Monophosphoryl Lipid A and QS21 Increase CD8 T Lymphocyte Cytotoxicity to Herpes Simplex Virus-2 Infected Cell Proteins 4 and 27 Through IFN-{gamma} and IL-12 Production J. Immunol., May 15, 2000; 164(10): 5167 - 5176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-I. Sin, V. Ayyavoo, J. Boyer, J. Kim, R. B. Ciccarelli, and D. B. Weiner Protective immune correlates can segregate by vaccine type in a murine herpes model system Int. Immunol., November 1, 1999; 11(11): 1763 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-I. Sin, J. J. Kim, R. L. Arnold, K. E. Shroff, D. McCallus, C. Pachuk, S. P. McElhiney, M. W. Wolf, S. J. Pompa-de Bruin, T. J. Higgins, et al. IL-12 Gene as a DNA Vaccine Adjuvant in a Herpes Mouse Model: IL-12 Enhances Th1-Type CD4+ T Cell-Mediated Protective Immunity Against Herpes Simplex Virus-2 Challenge J. Immunol., March 1, 1999; 162(5): 2912 - 2921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Koelle, J. M. Frank, M. L. Johnson, and W. W. Kwok Recognition of Herpes Simplex Virus Type 2 Tegument Proteins by CD4 T Cells Infiltrating Human Genital Herpes Lesions J. Virol., September 1, 1998; 72(9): 7476 - 7483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z Mikloska and A. Cunningham Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes J. Gen. Virol., February 1, 1998; 79(2): 353 - 361. [Abstract]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
